Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 42, Issue 6, Pages 785-793
Publisher
Oxford University Press (OUP)
Online
2021-05-25
DOI
10.1093/carcin/bgab043
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ovarian Cancer Screening: Current status and future directions
- (2020) Zachary Nash et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Risk-Adjusted Model for Ovarian Cancer Care and Disparities in Access to High-Performing Hospitals
- (2020) Robert E. Bristow et al. OBSTETRICS AND GYNECOLOGY
- Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment
- (2020) Eleni Maniati et al. Cell Reports
- Prognostic gene expression signature for high-grade serous ovarian cancer
- (2020) J. Millstein et al. ANNALS OF ONCOLOGY
- Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study
- (2020) Dmitriy Zamarin et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer
- (2020) Sanghoon Lee et al. Cell Reports
- Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
- (2020) Pauline Krämer et al. CLINICAL CANCER RESEARCH
- Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
- (2020) Aline Talhouk et al. CLINICAL CANCER RESEARCH
- Prediction of the treatment response in ovarian cancer: a ctDNA approach
- (2020) Mina Sharbatoghli et al. Journal of Ovarian Research
- Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses’ Health Studies
- (2019) Renée T. Fortner et al. BRITISH JOURNAL OF CANCER
- Molecular classification of epithelial ovarian cancer based on methylation profiling: evidence for survival heterogeneity
- (2019) Clara Bodelon et al. CLINICAL CANCER RESEARCH
- The influence of birth cohort and calendar period on global trends in ovarian cancer incidence
- (2019) Citadel J. Cabasag et al. INTERNATIONAL JOURNAL OF CANCER
- An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
- (2019) Oded Kopper et al. NATURE MEDICINE
- Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses
- (2019) Aleksandra Gentry-Maharaj et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- High levels of C-reactive protein are associated with an increased risk of ovarian cancer: Results from the Ovarian Cancer Cohort Consortium
- (2019) Lauren C Peres et al. CANCER RESEARCH
- TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7)
- (2019) Alexander Reuss et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
- (2019) Robert L. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The molecular origin and taxonomy of mucinous ovarian carcinoma
- (2019) Dane Cheasley et al. Nature Communications
- Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma
- (2019) Shuang Zhang et al. Nature Communications
- Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review
- (2019) Sander Dumont et al. Journal of Ovarian Research
- Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts
- (2019) Kevin W. McCool et al. CANCER RESEARCH
- Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study
- (2018) C.A. Hamilton et al. GYNECOLOGIC ONCOLOGY
- Screening for Ovarian Cancer
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium
- (2018) Britton Trabert et al. JNCI-Journal of the National Cancer Institute
- Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
- (2018) Lauren C Peres et al. JNCI-Journal of the National Cancer Institute
- Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations
- (2018) Britton Trabert et al. JNCI-Journal of the National Cancer Institute
- Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium
- (2018) Britton Trabert et al. JNCI-Journal of the National Cancer Institute
- Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
- (2018) Lauren C Peres et al. JNCI-Journal of the National Cancer Institute
- Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations
- (2018) Britton Trabert et al. JNCI-Journal of the National Cancer Institute
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Copy number signatures and mutational processes in ovarian carcinoma
- (2018) Geoff Macintyre et al. NATURE GENETICS
- Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer
- (2018) Nicole D. Fleming et al. OBSTETRICS AND GYNECOLOGY
- Associations of early life and adulthood adiposity with risk of epithelial ovarian cancer
- (2018) T Huang et al. ANNALS OF ONCOLOGY
- Anti-Inflammatory Drug Use and Ovarian Cancer Risk by COX1/COX2 Expression and Infiltration of Tumor-Associated Macrophages
- (2018) Mollie E. Barnard et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The fallopian tube, “precursor escape” and narrowing the knowledge gap to the origins of high-grade serous carcinoma
- (2018) Thing Rinda Soong et al. GYNECOLOGIC ONCOLOGY
- Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes
- (2018) Lydia Giannopoulou et al. Translational Research
- Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors
- (2018) S. Y. Cindy Yang et al. Genome Medicine
- A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer
- (2017) Rudy S. Suidan et al. GYNECOLOGIC ONCOLOGY
- International patterns and trends in ovarian cancer incidence, overall and by histologic subtype
- (2017) S.B. Coburn et al. INTERNATIONAL JOURNAL OF CANCER
- Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario
- (2017) Jacob McGee et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease
- (2017) Yali Zhai et al. JOURNAL OF PATHOLOGY
- Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries
- (2017) Britton Trabert et al. JNCI-Journal of the National Cancer Institute
- Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B Kuchenbaecker et al. JNCI-Journal of the National Cancer Institute
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Robert L Coleman et al. LANCET
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
- (2017) Catherine M Phelan et al. NATURE GENETICS
- Cancer-Associated Mutations in Endometriosis without Cancer
- (2017) Michael S. Anglesio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
- (2017) Olga Kondrashova et al. Cancer Discovery
- Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries
- (2017) Britton Trabert et al. JNCI-Journal of the National Cancer Institute
- Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B Kuchenbaecker et al. JNCI-Journal of the National Cancer Institute
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas
- (2016) Peter F Rambau et al. HISTOPATHOLOGY
- Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing
- (2016) Paul A. Cohen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- An Immunohistochemical Algorithm for Ovarian Carcinoma Typing
- (2016) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium
- (2016) Nicolas Wentzensen et al. JOURNAL OF CLINICAL ONCOLOGY
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian cancer
- (2016) Ursula A. Matulonis et al. Nature Reviews Disease Primers
- The optimal organization of gynecologic oncology services: a systematic review
- (2015) M. Fung-Kee-Fung et al. Current Oncology
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours
- (2015) Tan A. Ince et al. Nature Communications
- Tumorgrafts asIn VivoSurrogates for Women with Ovarian Cancer
- (2014) S. John Weroha et al. CLINICAL CANCER RESEARCH
- Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
- (2014) Amy P.M. Finch et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drug, and Acetaminophen Use and Risk of Invasive Epithelial Ovarian Cancer: A Pooled Analysis in the Ovarian Cancer Association Consortium
- (2014) B. Trabert et al. JNCI-Journal of the National Cancer Institute
- Coming into focus: the nonovarian origins of ovarian cancer
- (2013) L. Dubeau et al. ANNALS OF ONCOLOGY
- Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
- (2013) Ruth Perets et al. CANCER CELL
- Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
- (2013) Michael S. Anglesio et al. PLoS One
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
- (2012) N. Mavaddat et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?
- (2012) Ignace Vergote et al. GYNECOLOGIC ONCOLOGY
- BRCA, the Oviduct, and the Space and Time Continuum of Pelvic Serous Carcinogenesis
- (2012) Christopher P. Crum et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
- (2012) Celeste Leigh Pearce et al. LANCET ONCOLOGY
- High-grade serous ovarian cancer arises from fallopian tube in a mouse model
- (2012) J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Risk-Reducing Salpingo-Oophorectomy (RRSO) in BRCA Mutation Carriers
- (2011) C. Bethan Powell et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?
- (2010) Christopher G. Przybycin et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The National Cancer Database report on advanced-stage epithelial ovarian cancer: Impact of hospital surgical case volume on overall survival and surgical treatment paradigm
- (2010) Robert E. Bristow et al. GYNECOLOGIC ONCOLOGY
- Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
- (2009) Michael A. Bookman et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review
- (2008) Andreas du Bois et al. GYNECOLOGIC ONCOLOGY
- Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design
- (2008) Margaret S. Pepe et al. JNCI-Journal of the National Cancer Institute
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started